Clinical trials
Phase 2 Uterine Cervical Neoplasms trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2017 | 2 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2024 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 4 |
| Active, not recruiting | 3 |
| Recruiting | 3 |
| Terminated | 3 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hoffmann-La Roche | 2 |
| AstraZeneca | 1 |
| Cambridge University Hospitals NHS Foundation Trust | 1 |
| Daiichi Sankyo | 1 |
| European Organisation for Research and Treatment of Cancer - EORTC | 1 |
| Institute of Cancer Research, United Kingdom | 1 |
| Iovance Biotherapeutics, Inc. | 1 |
| Seagen Inc. | 1 |
| Seagen, a wholly owned subsidiary of Pfizer | 1 |
| The Clatterbridge Cancer Centre NHS Foundation Trust | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Uterine Cervical Neoplasms | 14 |
| Carcinoma, Non-Small-Cell Lung | 4 |
| Endometrial Neoplasms | 4 |
| Ovarian Neoplasms | 4 |
| Breast Neoplasms | 3 |
| Esophageal Neoplasms | 2 |
| Melanoma | 2 |
| Pancreatic Neoplasms | 2 |
| Prostatic Neoplasms | 2 |
| Squamous Cell Carcinoma of Head and Neck | 2 |
Trials
Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.